期刊文献+

不同剂量的甲状旁腺素对成骨细胞分化的不同作用的实验研究 被引量:1

Effect of the different dose of parathyroid hormone on osteoblast differentiation: an experimental study
下载PDF
导出
摘要 目的探讨不同剂量的甲状旁腺素(PTH)对成骨细胞分化过程的影响。方法培养MC3T3-E1成骨前体细胞,给与不同浓度的PTH处理细胞,real-time PCR方法,检测细胞内成骨因子基因mRNA的表达;碱性磷酸酶(ALP)染色方法,检测细胞内ALP的分泌;Alizarin Red染色方法,检测细胞内成骨钙化作用。结果 1 nmol/L浓度的PTH和10 nmol/L浓度的PTH都具有明显的促进成骨细胞分化的作用,以10 nmol/L浓度的PTH的作用更强。100 nmol/L较高浓度的PTH没有明显促进成骨细胞分化的作用。结论不同剂量的PTH对成骨细胞的分化作用,具有不同的影响。 Objective To investigate the effect of the different dose of parathyroid hormone ( PTH) on osteoblast differentiation. Methods MC3T3-E1 cells were cultured.Different dose of PTH was additioned to the medium.The mRNA expression of osteoblastic markers was determined using real-time PCR.The secretion of alkaline phosphatase ( ALP) in the cells was detected using ALP staining method.The mineralization was detected using Alizarin red staining.Results Compared with the control, both 1nM PTH and 10nM PTH could significantly stimulate the osteoblast differentiation, and the effect of 10 nmol/LPTH was much stronger.But no significant stimulating effect of 100nmol/L PTH on the osteoblast differentiation was observed.Conclusion Different dose of parathyroid hormone exerts different effect on the osteoblast differentiation .
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2014年第6期614-617,661,共5页 Chinese Journal of Osteoporosis
基金 辽宁省自然科学基金(2013021052)
关键词 甲状旁腺素 成骨细胞 分化 剂量 Parathyroid hormone Osteoblast Differentiation Dose
  • 相关文献

参考文献12

  • 1Kent GN, Loveridge N, Reeve J, et al. Phammcokinetics of synthetic human parathyroid hormone 1-34 in man measured by cytochemical bioassay and radioimmunoassay. Clin Sci (Lond) , 1985,68(2) :171-177.
  • 2Dempster DW, Cosman F, Kurland ES, et al. Effects of daily treatment with parathyroid hormone on bone micro architecture and turnover in patients with osteoporosis : a paired biopsy study. J Bone Miner Res,2001, 16(10) :1846-1853.
  • 3Barnes GL, Kostenuik PJ, Gerstenfeld LC, et al. Growth of factor regulation of fracture repair. J Bone Miner Res, 1999,14 (11) :1805-1815.
  • 4Simmons DJ. Fracture healing perspectives. Clin Orthop Relat of Res, 1985,200:100-113.
  • 5Ming N, Cheng JT, Rui YF, et al. Dose-dependent enhancement of spinal fusion in rats with teriparatide ( PTH [ 1- 34] ). Spine, 2012,37(15) :1275-1282.
  • 6Van der Horst G, Farih-Sips H, Lwik CW, et al. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells. J Bone Miner Res, 2005, 20(12) : 2233-2244.
  • 7Robling AG, Kedlaya R, Ellis SN, et al. Anabolic and catabolic regimens of human parathyroid hormone 1-34 elieit bone- and envelope-specific attenuation of skeletal effects in Sost-defieient mice. Endocrinology,2011,152(8 ) : 2963-2975.
  • 8Kim SW, Pajevic PD, Selig M, et al. Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts. J Bone Miner Res, 2012, 27(10) :2075-2084.
  • 9Gafni RI, Brahim JS, Andreopoulou P, et al. Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. J Bone Miner Res, 2012, 27(8) : 1811-1120.
  • 10Aspenberg P, Genant HK, Johansson T, et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res, 2010, 25 (2) : 404-414.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部